Kither Biotech is a pharmaceutical product company that developmens of new drugs to treat chronic inflammatory diseases
Kither Biotech has raised $20.4M in total funding. The most recent round was Series B. The last funding was announced in March 2022.
Kither Biotech's investors include CDP Venture Capital, Claris Ventures, Invitalia Ventures, 3B Future Health Fund, Italian Angels for Growth.
Kither Biotech is headquartered in Torino, Italy.
Kither Biotech is a pharmaceutical product company that developmens of new drugs to treat chronic inflammatory diseases
Kither Biotech is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Kither Biotech — Funding & Investors." VCBacked, March 16, 2022, https://www.vcbacked.co/company/kither-biotech. Accessed August 14, 2026.
VCBacked. (2022). Kither Biotech — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/kither-biotech
{{cite web |title=Kither Biotech — Funding & Investors |url=https://www.vcbacked.co/company/kither-biotech |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated